245 related articles for article (PubMed ID: 38081931)
21. Inhibition of SLC7A11-GPX4 signal pathway is involved in aconitine-induced ferroptosis in vivo and in vitro.
Li Q; Peng F; Yan X; Chen Y; Zhou J; Wu S; Jiang W; Jin X; Liang J; Peng C; Pan X
J Ethnopharmacol; 2023 Mar; 303():116029. PubMed ID: 36503029
[TBL] [Abstract][Full Text] [Related]
22. Ferroptosis as a p53-mediated activity during tumour suppression.
Jiang L; Kon N; Li T; Wang SJ; Su T; Hibshoosh H; Baer R; Gu W
Nature; 2015 Apr; 520(7545):57-62. PubMed ID: 25799988
[TBL] [Abstract][Full Text] [Related]
23. Simultaneous inhibition of FAK and ROS1 synergistically repressed triple-negative breast cancer by upregulating p53 signalling.
Tan X; Kong D; Tao Z; Cheng F; Zhang B; Wang Z; Mei Q; Chen C; Wu K
Biomark Res; 2024 Jan; 12(1):13. PubMed ID: 38273343
[TBL] [Abstract][Full Text] [Related]
24. p53 Activates the Lipoxygenase Activity of ALOX15B via Inhibiting SLC7A11 to Induce Ferroptosis in Bladder Cancer Cells.
Li X; Xiong W; Wang Y; Li Y; Cheng X; Liu W
Lab Invest; 2023 May; 103(5):100058. PubMed ID: 36801644
[TBL] [Abstract][Full Text] [Related]
25. The oncoprotein gankyrin negatively regulates both p53 and RB by enhancing proteasomal degradation.
Higashitsuji H; Liu Y; Mayer RJ; Fujita J
Cell Cycle; 2005 Oct; 4(10):1335-7. PubMed ID: 16177571
[TBL] [Abstract][Full Text] [Related]
26. MDM2 and MDMX promote ferroptosis by PPARĪ±-mediated lipid remodeling.
Venkatesh D; O'Brien NA; Zandkarimi F; Tong DR; Stokes ME; Dunn DE; Kengmana ES; Aron AT; Klein AM; Csuka JM; Moon SH; Conrad M; Chang CJ; Lo DC; D'Alessandro A; Prives C; Stockwell BR
Genes Dev; 2020 Apr; 34(7-8):526-543. PubMed ID: 32079652
[TBL] [Abstract][Full Text] [Related]
27. Progress in the research of p53 tumour suppressor activity controlled by Numb in triple-negative breast cancer.
Xian J; Cheng Y; Qin X; Cao Y; Luo Y; Cao Y
J Cell Mol Med; 2020 Jul; 24(13):7451-7459. PubMed ID: 32501652
[TBL] [Abstract][Full Text] [Related]
28. Shenshuaifu Granule Attenuates Acute Kidney Injury by Inhibiting Ferroptosis Mediated by p53/SLC7A11/GPX4 Pathway.
Jin X; He R; Lin Y; Liu J; Wang Y; Li Z; Liao Y; Yang S
Drug Des Devel Ther; 2023; 17():3363-3383. PubMed ID: 38024532
[TBL] [Abstract][Full Text] [Related]
29. SRSF1 inhibits ferroptosis and reduces cisplatin chemosensitivity of triple-negative breast cancer cells through the circSEPT9/GCH1 axis.
Song X; Wang X; Chen X; Yu Z; Zhou Y
J Proteomics; 2024 Feb; 292():105055. PubMed ID: 38040194
[TBL] [Abstract][Full Text] [Related]
30. Jing-Fang n-butanol extract and its isolated JFNE-C inhibit ferroptosis and inflammation in LPS induced RAW264.7 macrophages via STAT3/p53/SLC7A11 signaling pathway.
Li X; Qi H; Zhang X; Liang H; Zeng N
J Ethnopharmacol; 2023 Nov; 316():116689. PubMed ID: 37315642
[TBL] [Abstract][Full Text] [Related]
31. A PARP1 PROTAC as a novel strategy against PARP inhibitor resistance via promotion of ferroptosis in p53-positive breast cancer.
Li G; Lin SS; Yu ZL; Wu XH; Liu JW; Tu GH; Liu QY; Tang YL; Jiang QN; Xu JH; Huang QL; Wu LX
Biochem Pharmacol; 2022 Dec; 206():115329. PubMed ID: 36309080
[TBL] [Abstract][Full Text] [Related]
32. Discovery of ganoderic acid A (GAA) PROTACs as MDM2 protein degraders for the treatment of breast cancer.
Li Y; Li G; Zuo C; Wang X; Han F; Jia Y; Shang H; Tian Y
Eur J Med Chem; 2024 Apr; 270():116367. PubMed ID: 38581732
[TBL] [Abstract][Full Text] [Related]
33. Synthetic Proteins Potently and Selectively Bind the Oncoprotein Gankyrin, Modulate Its Interaction with S6 ATPase, and Suppress Gankyrin/MDM2-Dependent Ubiquitination of p53.
Chapman AM; McNaughton BR
ACS Chem Biol; 2015 Aug; 10(8):1880-6. PubMed ID: 25955581
[TBL] [Abstract][Full Text] [Related]
34. PHGDH Inhibits Ferroptosis and Promotes Malignant Progression by Upregulating SLC7A11 in Bladder Cancer.
Shen L; Zhang J; Zheng Z; Yang F; Liu S; Wu Y; Chen Y; Xu T; Mao S; Yan Y; Li W; Zhang W; Yao X
Int J Biol Sci; 2022; 18(14):5459-5474. PubMed ID: 36147463
[No Abstract] [Full Text] [Related]
35. Plumbagin induces ferroptosis in colon cancer cells by regulating p53-related SLC7A11 expression.
Wang B; Kong W; Lv L; Wang Z
Heliyon; 2024 Apr; 10(7):e28364. PubMed ID: 38596137
[TBL] [Abstract][Full Text] [Related]
36. SOCS1 acts as a ferroptosis driver to inhibit the progression and chemotherapy resistance of triple-negative breast cancer.
Wang Y; Pang X; Liu Y; Mu G; Wang Q
Carcinogenesis; 2023 Dec; 44(8-9):708-715. PubMed ID: 37665951
[TBL] [Abstract][Full Text] [Related]
37. Regulation of Mdm2 protein stability and the p53 response by NEDD4-1 E3 ligase.
Xu C; Fan CD; Wang X
Oncogene; 2015 Jan; 34(3):281-9. PubMed ID: 24413081
[TBL] [Abstract][Full Text] [Related]
38. Ferroptosis-enhanced chemotherapy for triple-negative breast cancer with magnetic composite nanoparticles.
Zhang J; Zhou K; Lin J; Yao X; Ju D; Zeng X; Pang Z; Yang W
Biomaterials; 2023 Dec; 303():122395. PubMed ID: 37988899
[TBL] [Abstract][Full Text] [Related]
39. Enigma negatively regulates p53 through MDM2 and promotes tumor cell survival in mice.
Jung CR; Lim JH; Choi Y; Kim DG; Kang KJ; Noh SM; Im DS
J Clin Invest; 2010 Dec; 120(12):4493-506. PubMed ID: 21060154
[TBL] [Abstract][Full Text] [Related]
40. Knockdown of HURP inhibits the proliferation of hepacellular carcinoma cells via downregulation of gankyrin and accumulation of p53.
Kuo TC; Chang PY; Huang SF; Chou CK; Chao CC
Biochem Pharmacol; 2012 Mar; 83(6):758-68. PubMed ID: 22230478
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
